Diseases [C] » Nutritional and Metabolic Diseases [C18] » Metabolic Diseases » Lipid Metabolism Disorders » Dyslipidemias » Hyperlipidemias » Hyperlipoproteinemias
Description
Conditions with abnormally elevated levels of LIPOPROTEINS in the blood. They may be inherited, acquired, primary, or secondary. Hyperlipoproteinemias are classified according to the pattern of lipoproteins on electrophoresis or ultracentrifugation. MeSH
Hierarchy View
Subtype Terms (5)
Hyperlipoproteinemia Type I
10 drugs (5 approved, 5 experimental)
Hyperlipoproteinemia Type II
41 drugs (20 approved, 21 experimental)
Hyperlipoproteinemia Type III
6 drugs (5 approved, 1 experimental)
Hyperlipoproteinemia Type IV
7 drugs (4 approved, 3 experimental)
Hyperlipoproteinemia Type V
4 drugs (1 approved, 3 experimental)
Approved Indicated Drugs (1)
Phase 4 Indicated Drugs (2)
Phase 3 Indicated Drugs (7)
Phase 2 Indicated Drugs (2)
Organization Involved with Phase 4 Indications (62)
American Society of Health-System Pharmacists Research and Education Foundation
Chestnut Hill Temple Cardiology
French National Agency for Research on AIDS and Viral Hepatitis
Garvan Institute of Medical Research
In His Image Family Medicine Residency
Institute for Health Research IdiPAZ
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Organization Involved with Phase 3 Indications (48)
Organization Involved with Phase 2 Indications (37)
National Center for Complementary and Integrative Health (NCCIH)
National Center for Research Resources (NCRR)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Child Health and Human Development (NICHD)
National Institutes of Health (NIH)
Organization Involved with Phase 1 Indications (16)
Organization Involved with Other Experimental Indications (20)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
